| Business Summary | | Fisher
Scientific
International
Inc.
engages
in
the
supply,
marketing,
service
and
manufacture
of
scientific,
clinical,
educational,
occupational
health
and
safety
products.
The
Company
offers
more
than
600,000
products
and
services
that
enable
scientific
discovery,
and
healthcare
services
to
more
than
350,000
customers
located
in
approximately
145
countries.
As
a
result
of
its
broad
product
offering,
integrated
global
logistic
infrastructure
and
e-commerce
capabilities,
the
Company
serves
as
a
"one-stop
source"
of
products,
services
and
global
solutions
for
many
of
its
customers.
Its
primary
target
markets
are
life
science,
clinical
laboratory
and
industrial
safety
supply.
Approximately
80%
of
its
revenues
are
generated
from
the
sale
of
consumable
products. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | FSH
engages
in
the
supply,
marketing,
service
and
manufacture
of
scientific,
clinical,
educational,
safety
products
and
occupational
health.
FSH
also
manufactures
laboratory
workstations.
For
the
six
months
ended
6/30/01,
sales
rose
6%
to
$1.4
billion.
Net
loss
totaled
$11.5
million,
vs.
an
income
of
$17.9
million.
Sales
reflect
increased
demand
in
the
research
and
healthcare
markets
and
increased
e-commerce
sales.
Net
loss
reflects
a
$51.6
million
restructuring
charge. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Paul Montrone, 59 Chairman,
CEO | $1.5M | David Della Penta, 53 Pres
and COO | 964K | Paul Meister, 48 Vice
Chairman, Exec. VP | 1.0M | Kevin Clark, 38 CFO,
VP | 436K | Todd DuChene, 37 VP,
Gen. Counsel, Sec. | 448K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|